Mercer Global Advisors
VIR icon

Mercer Global Advisors’s Vir Biotechnology VIR Stock Holding History

Mercer Global Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Sell
25,750
-4,190
-14% -$39.9K ﹤0.01% 2948
2026
Q1 		$268K Buy
+29,940
New +$239K ﹤0.01% 2551
2023
Q3 		– Sell
-47,560
Closed -$1.17M – 2062
2023
Q2 		$1.17M Buy
47,560
+7,831
+20% +$197K ﹤0.01% 895
2023
Q1 		$924K Buy
39,729
+3,865
+11% +$98.9K ﹤0.01% 944
2022
Q4 		$908K Buy
35,864
+1,414
+4% +$34.7K ﹤0.01% 960
2022
Q3 		$664K Buy
+34,450
New +$876K ﹤0.01% 1017

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mercer Global Advisors's VIR Position: Q2 2026 in Review

Mercer Global Advisors reduced its Vir Biotechnology (VIR) stake by 14% in Q2 2026, selling an estimated $39.9K and leaving 25,750 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Mercer Global Advisors first reported a position in VIR in Q3 2022 and has held it in 6 quarters since. The position peaked at $1.17M in Q2 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Mercer Global Advisors held 25,750 shares of Vir Biotechnology worth $262K as of Q2 2026.
  • Mercer Global Advisors sold 4,190 Vir Biotechnology shares in Q2 2026, an estimated $39.9K.
  • Vir Biotechnology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2948 holding.
  • Mercer Global Advisors first reported a position in Vir Biotechnology in Q3 2022 and has held it in 6 quarters since.
  • Mercer Global Advisors's Vir Biotechnology position peaked at $1.17M in Q2 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.